JP Morgan Chase’s Oculis Holding OCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Sell
24,846
-28,199
-53% -$640K ﹤0.01% 5346
2026
Q1
$1.3M Buy
53,045
+49,865
+1,568% +$1.32M ﹤0.01% 4418
2025
Q4
$63.5K Buy
+3,180
New +$63.6K ﹤0.01% 6118
2025
Q2
Sell
-600
Closed -$11.4K 7488
2025
Q1
$11.4K Buy
+600
New +$12.3K ﹤0.01% 6273
2024
Q4
Sell
-1
Closed -$12 7628
2024
Q3
$12 Hold
1
﹤0.01% 7280
2024
Q2
$12 Hold
1
﹤0.01% 7199
2024
Q1
$12 Buy
+1
New +$12 ﹤0.01% 7218

Other funds holding OCS

JP Morgan Chase's OCS Position: Q2 2026 in Review

JP Morgan Chase reduced its Oculis Holding (OCS) stake by 53% in Q2 2026, selling an estimated $640K and leaving 24,846 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #5346.

JP Morgan Chase first reported a position in OCS in Q1 2024 and has held it in 7 quarters since. The position peaked at $1.3M in Q1 2026. 59 funds tracked by Wall St. Rank hold OCS as of Q2 2026.

  • JP Morgan Chase held 24,846 shares of Oculis Holding worth $325K as of Q2 2026.
  • JP Morgan Chase sold 28,199 Oculis Holding shares in Q2 2026, an estimated $640K.
  • Oculis Holding made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5346 holding.
  • JP Morgan Chase first reported a position in Oculis Holding in Q1 2024 and has held it in 7 quarters since.
  • JP Morgan Chase's Oculis Holding position peaked at $1.3M in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Oculis Holding as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.